View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
February 28, 2022

M&A activity driving growth of assisted reproductive technology devices market in Q1 2022

According to GlobalData’s latest market model, the ART devices market is set to grow at a compound annual growth rate of 6%.

By GlobalData

The Assisted Reproductive Technology (ART) devices market, consisting of single-use devices in in vitro fertilisation (IVF) and intrauterine insemination (IUI) procedures, has historically experienced several merger and acquisition (M&A) activities. These were mostly led by CooperSurgical, which has acquired several companies, or divisions of companies, such as Research Instruments, The Pipette Company, and notably the Wallace product lines of Smiths Medical International, all in 2016. Two years later, CooperSurgical acquired The LifeGlobal Group, the result of which solidified CooperSurgical as one of the leaders in this market.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Until recently, CooperSurgical’s longstanding competitor within the ART devices market was Cook Medical. Therefore, the announcement earlier this month of CooperSurgical acquiring the Reproductive Health business division of Cook Medical, for $875 million, indicates that CooperSurgical will dominate this market globally for the foreseeable future.

According to GlobalData’s latest market model, the ART devices market is set to grow at a compound annual growth rate of 6%, resulting in a global market value exceeding $440 million by 2030. This is following a highly tumultuous 2020, when IVF device sales temporarily experienced unprecedented losses, because most elective medical procedures were postponed due to the Covid-19 pandemic. However, sales showed a strong recovery in H2 2020, offsetting the initial losses, due to the backlog of procedure volumes and associated device sales.

Shortly after the initial Covid-19 lockdown when policies were relaxed in Q3 2020 across much of the world and elective procedures started resuming, most fertility clinics also resumed operations. Thus, the market for IVF devices rebounded rapidly and experienced a remarkable surge in sales in Q3 2020. In the US, sales trends throughout 2021, and thus far in 2022, indicate a return to pre-pandemic growth levels, and GlobalData forecasts the global market to completely stabilise by mid-2022.

Some of the key drivers of the global market growth in IVF device sales are the increasing number of fertility clinics, an increase in the average age of couples choosing to have children, and an increasing number of women opting to undergo IVF because it improves pregnancy success rates. Emerging technologies will also play a role in drawing more patients, such as time-lapse embryo culture, and artificial intelligence, whereby patient profiles and embryo development are quantitatively assessed to improve pregnancy success rates using the healthiest embryos.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network